| AA | anthranilic acid |
| AhR | aryl hydrocarbon receptor |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| APC | antigen-presenting cell |
| ASD | autism spectrum disorder |
| ATP | adenosine triphosphate |
| BBB | blood-brain barrier |
| BD | bipolar disorder |
| CA | cinnabarinic acid |
| CCBL | cysteine conjugate beta-lyase |
| CNS | central nervous system |
| CRP | C-reactive protein |
| CSF | cerebrospinal fluid |
| CUD | cocaine use disorder |
| DSM-5 | Diagnostic and Treatment Manual for Mental Disorders, Fifth Edition |
| EEG | electroencephalography |
| FEP | first-episode psychosis |
| GAD | generalized anxiety disorder |
| GPR35 | G-protein coupled receptor 35 |
| 3-HAA | 3-hydroxyanthranilic acid |
| 3-HK | 3-hydroxy-kynurenine |
| HD | Huntington’s disease |
| HRQL | Health-Related Quality of Life |
| 5-HT | serotonin, 5-hydroxytryptamine |
| IDO | indoleamine 2,3-dioxygenase |
| IFN | interferon |
| IL | interleukin |
| iNKT | invariant natural killer cell |
| KATs | kynurenine aminostransferase |
| KMO | kynurenine 3-monooxygenase |
| KP | kynurenine pathway |
| KYN | kynurenine |
| KYNA | kynurenic acid |
| LGI | low-grade inflammation |
| MCP | monocyte chemoattractant protein |
| MDD | major depressive disorder |
| MS | multiple sclerosis |
| MT | melatonin |
| NAD+ | nicotinamide adenine dinucleotide |
| NADPH | nicotinamide adenosine dinucleotide phosphate |
| NK | natural killer cell |
| PD | Parkinson’s disease |
| PIC | picolinic acid |
| PTSD | post-traumatic stress disorder |
| QUIN | quinolinic acid |
| ROS | reactive oxygen species |
| SANS | Scale for the Assessment of Negative Symptoms |
| SCZ | schizophrenia |
| sIL-2R | soluble IL-2 receptor |
| SjS | Sjögren’s syndrome |
| SLE | systemic lupus erythematosus |
| SUD | substance use disorder |
| SWS | slow wave sleep |
| TDO | tryptophan 2,3-dioxygenase |
| Th1 | T helper type 1 |
| Th17 | T helper type 17 |
| Th2 | T helper type 2 |
| TNF | tumor necrosis factor |
| TRP | tryptophan |
| XA | xanthurenic acid |